Interactive Voice Response System in Advanced Cancer Patients
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/6/2018 |
| Start Date: | January 2008 |
| End Date: | January 2020 |
Symptom Assessment in Advanced Cancer Patients Using an Interactive Voice Response (IVR) System
The goal of this research study is to learn if using an Interactive Voice Response (IVR)
system can bring about better and more timely symptom control for patients with advanced
cancer.
Primary Objectives:
- To determine whether the Interactive Voice Response (IVR) system, supplemented by
Nursing Telephone Intervention (NTI), results in better symptom management and quality
of life than standard care for individuals with advanced cancer as evidenced by reduced
scores on symptom measures.
- To determine whether the IVR system, supplemented by NTI, results in reduced caregiver
burden, increased caregiver satisfaction with care, and improved coping strategies.
- To determine the feasibility of using an IVR system, supplemented by NTI, for symptom
assessment in individuals with advanced cancer and their caregivers by conducting a
process evaluation of the system. Variables to be evaluated include rates of participant
recruitment and retention, frequency of use of the system, acceptability of the system
to participants, and barriers to participation. Researchers' goal is to identify and
improve aspects that affect external validity (recruitment rate, cohort maintenance),
internal validity (implementation, contamination), participant acceptability and
satisfaction, and reaction to study procedures. The findings from this evaluation will
also allow researchers to evaluate delivery of interventions in future studies.
system can bring about better and more timely symptom control for patients with advanced
cancer.
Primary Objectives:
- To determine whether the Interactive Voice Response (IVR) system, supplemented by
Nursing Telephone Intervention (NTI), results in better symptom management and quality
of life than standard care for individuals with advanced cancer as evidenced by reduced
scores on symptom measures.
- To determine whether the IVR system, supplemented by NTI, results in reduced caregiver
burden, increased caregiver satisfaction with care, and improved coping strategies.
- To determine the feasibility of using an IVR system, supplemented by NTI, for symptom
assessment in individuals with advanced cancer and their caregivers by conducting a
process evaluation of the system. Variables to be evaluated include rates of participant
recruitment and retention, frequency of use of the system, acceptability of the system
to participants, and barriers to participation. Researchers' goal is to identify and
improve aspects that affect external validity (recruitment rate, cohort maintenance),
internal validity (implementation, contamination), participant acceptability and
satisfaction, and reaction to study procedures. The findings from this evaluation will
also allow researchers to evaluate delivery of interventions in future studies.
If you and your caregiver agree to take part in this study, you will be randomly assigned (as
in the toss of the coin) to be in 1 of 2 groups. Group A will receive standard of care
provided at the palliative center at M. D. Anderson, but will not receive any phone calls
from the Interactive Voice Response (IVR) system. Group B will receive phone calls by the
Interactive Voice Response (IVR) system on Monday, Wednesday, and Friday for 15 days.
Once you sign this consent form, you will answer questions about your diagnosis, the
medication that you take, and the symptoms that you are having (for example, pain, fatigue,
anxiety, depression, and overall feeling of well-being). You will either be asked these
questions verbally or you will complete a written questionnaire. This should take about 30
minutes to complete.
If you and your caregiver are assigned to Group A, you will continue with the standard of
care provided at the palliative center at M. D. Anderson. On Day 15, both you and your
caregiver will be seen in the outpatient clinic by the research nurse, and complete the same
questionnaire you had at the beginning of the study, either verbally or written. This should
take about 30 minutes to complete.
If you and your caregiver are assigned to Group B, a research nurse will train you and your
caregiver to operate the IVR system. The IVR call will be made to the preferred telephone
number(s) provided by you and your caregiver. The telephone calls will be made 1 time a day
at times chosen by you and your caregiver. You will both be given a 3-digit code number to
enter as a way of confirming who you are.
Once you have entered the requested numbers, the IVR system will ask you to answer questions
about pain, fatigue, anxiety, depression, and your overall feeling of well-being. These phone
calls should take about 3-5 minutes to complete. You should complete the phone calls
separately and should not attempt to influence each others answers.
A research nurse will review the answer in the IVR system. If you haven't responded to the
IVR questions in 3 days, if you answer that you would like to be contacted by a nurse, or if
a symptom has reached a concerning level, you and your caregiver will receive a phone call
from the nurse. The nurse may ask about symptoms, medications being taken, concerns or doubts
about the medication, and if you have any concerns about your physical or emotional well
being. You will be reminded of the different telephone numbers you can use to receive
assistance 24 hours a day. During the phone call, you will also be asked if you would like
the nurse to contact your caregiver for information and support. If you agree, the nurse will
contact your caregiver.
On Day 8, both you and your caregiver will be contacted either in person or by phone by the
research nurse and will complete the same questionnaire you had at the beginning of the
study. On Day 15, both you and your caregiver will be seen in the outpatient clinic by the
research nurse and will complete this same questionnaire again, either verbally or written.
This should take about 30 minutes to complete each time.
Your participation on this study will end on Day 15.
This is an investigational study. Up to 68 patient-caregiver groups (or a total of 136
participants) will take part in this study. All the participants will be enrolled at M. D.
Anderson.
in the toss of the coin) to be in 1 of 2 groups. Group A will receive standard of care
provided at the palliative center at M. D. Anderson, but will not receive any phone calls
from the Interactive Voice Response (IVR) system. Group B will receive phone calls by the
Interactive Voice Response (IVR) system on Monday, Wednesday, and Friday for 15 days.
Once you sign this consent form, you will answer questions about your diagnosis, the
medication that you take, and the symptoms that you are having (for example, pain, fatigue,
anxiety, depression, and overall feeling of well-being). You will either be asked these
questions verbally or you will complete a written questionnaire. This should take about 30
minutes to complete.
If you and your caregiver are assigned to Group A, you will continue with the standard of
care provided at the palliative center at M. D. Anderson. On Day 15, both you and your
caregiver will be seen in the outpatient clinic by the research nurse, and complete the same
questionnaire you had at the beginning of the study, either verbally or written. This should
take about 30 minutes to complete.
If you and your caregiver are assigned to Group B, a research nurse will train you and your
caregiver to operate the IVR system. The IVR call will be made to the preferred telephone
number(s) provided by you and your caregiver. The telephone calls will be made 1 time a day
at times chosen by you and your caregiver. You will both be given a 3-digit code number to
enter as a way of confirming who you are.
Once you have entered the requested numbers, the IVR system will ask you to answer questions
about pain, fatigue, anxiety, depression, and your overall feeling of well-being. These phone
calls should take about 3-5 minutes to complete. You should complete the phone calls
separately and should not attempt to influence each others answers.
A research nurse will review the answer in the IVR system. If you haven't responded to the
IVR questions in 3 days, if you answer that you would like to be contacted by a nurse, or if
a symptom has reached a concerning level, you and your caregiver will receive a phone call
from the nurse. The nurse may ask about symptoms, medications being taken, concerns or doubts
about the medication, and if you have any concerns about your physical or emotional well
being. You will be reminded of the different telephone numbers you can use to receive
assistance 24 hours a day. During the phone call, you will also be asked if you would like
the nurse to contact your caregiver for information and support. If you agree, the nurse will
contact your caregiver.
On Day 8, both you and your caregiver will be contacted either in person or by phone by the
research nurse and will complete the same questionnaire you had at the beginning of the
study. On Day 15, both you and your caregiver will be seen in the outpatient clinic by the
research nurse and will complete this same questionnaire again, either verbally or written.
This should take about 30 minutes to complete each time.
Your participation on this study will end on Day 15.
This is an investigational study. Up to 68 patient-caregiver groups (or a total of 136
participants) will take part in this study. All the participants will be enrolled at M. D.
Anderson.
Inclusion Criteria:
1. Individuals with advanced cancer (incurable disease) who are seen in the Supportive
Care Center at M.D. Anderson Cancer Center.
2. Individuals with advanced cancer who have a pain score of 4 or higher on the average
pain scale item of the Brief Pain Inventory for at least 2 weeks
3. Individuals with advanced cancer who have a score of 4 or higher on pain and at least
one other symptom on the ESAS (fatigue, nausea, depression, anxiety, drowsiness,
shortness of breath, appetite, sleep).
4. Individuals with advanced cancer who are able to identify a primary caregiver who also
agrees to participate in the study
5. Individuals with advanced cancer who have no clinical evidence of cognitive failure in
the opinion of the referring MD.
6. Individuals with advanced cancer and caregivers who are at least 18 years of age
7. Individuals with advanced cancer and caregivers who have access and utilize a
touch-tone telephone
8. Individuals with advanced cancer and caregivers who are willing to engage in a
telephone follow-up with the IVR system and nurses every Monday, Wednesday and Friday.
9. Individuals with advanced cancer and caregivers who are willing to follow-up by phone
or in person on day 8 (+/- 3 days) and return for a follow-up visit on day 15 (+/-5
days)
10. Individuals with advanced cancer and caregivers who are willing and able to provide
written informed consent
11. Must be English speaking [The IVR only available in English]
12. Caregiver must be a partner, parent, sibling, or child of the individual with advanced
cancer.
13. Caregiver must reside with the individual with advanced cancer and be responsible for
most of the individual with advanced cancer's care
14. Individuals with advanced cancer and caregivers must be able to understand the
instructions for the study
Exclusion Criteria:
1. Individuals with advanced cancer or caregivers who cannot complete the baseline
assessment forms
2. Individuals with advanced cancer or caregivers who cannot understand the requirements
for participation in the study
3. Individuals with advanced cancer or caregivers who have hearing or visual impairments
severe enough to prevent use of the IVR or Nursing Telephone Intervention (NTI)
4. Individuals with advanced cancer or caregivers who cannot understand and speak English
(The IVR is only available in English)
5. Individuals with advanced cancer with caregivers who refuse to participate in the
study
6. If individuals with advanced cancer are found to screen positive for severe mood
disorders according to the HADS questionnaire for anxiety and/or depression, [ >/= to
20], they will be immediately referred to their primary palliative care physician for
initial assessment and management including potentially a referral to psychiatry.
Participants that are referred for psychiatric evaluation will be excluded from the
study.
7. Caregivers who are suspected to have severe mood disorders will be instructed to
contact their personal physician for assessment and management including potentially a
referral to psychiatry. Those that are referred for psychiatric evaluation will be
excluded from the study.
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
